Michael Christie

10.2k total citations · 1 hit paper
75 papers, 2.3k citations indexed

About

Michael Christie is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michael Christie has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Michael Christie's work include Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Genetic factors in colorectal cancer (10 papers). Michael Christie is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Genetic factors in colorectal cancer (10 papers). Michael Christie collaborates with scholars based in Australia, United States and United Kingdom. Michael Christie's co-authors include Peter Gibbs, Jayesh Desai, Jeanne Tie, Oliver M. Sieber, Hui‐Li Wong, Ben Tran, Robert N. Jorissen, Lara Lipton, Rachel Wong and Bert Vogelstein and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Christie

70 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

2015 464 citations Jeanne Tie, Isaac Kinde et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Christie Australia	20	1.1k	796	774	610	570	75	2.3k
Wentao Yang China	34	1.7k 1.5×	1.2k 1.5×	1.4k 1.8×	553 0.9×	590 1.0×	173	3.8k
Anne Hansen Ree Norway	30	1.3k 1.2×	661 0.8×	1.2k 1.5×	251 0.4×	506 0.9×	139	3.2k
Iain D. Miller United Kingdom	21	1.1k 1.0×	1.4k 1.8×	687 0.9×	520 0.9×	315 0.6×	36	3.1k
I E Smith United Kingdom	23	1.8k 1.6×	1.5k 1.9×	777 1.0×	457 0.7×	657 1.2×	59	3.5k
Gordan Srkalović United States	31	1.8k 1.6×	556 0.7×	1.6k 2.0×	167 0.3×	389 0.7×	91	3.6k
Michael Fraser Canada	24	562 0.5×	479 0.6×	1.4k 1.8×	227 0.4×	561 1.0×	47	2.3k
Jeremy Braybrooke United Kingdom	23	1.4k 1.2×	979 1.2×	1.0k 1.3×	210 0.3×	674 1.2×	64	2.9k
Masafumi Kurosumi Japan	37	2.2k 1.9×	1.8k 2.2×	1.4k 1.8×	747 1.2×	541 0.9×	202	4.3k
Kim M. Hirshfield United States	23	935 0.8×	624 0.8×	1.0k 1.3×	231 0.4×	287 0.5×	71	2.1k
Charles Cox United States	21	1.4k 1.2×	665 0.8×	1.1k 1.5×	664 1.1×	392 0.7×	42	2.6k

Countries citing papers authored by Michael Christie

Since Specialization

Citations

This map shows the geographic impact of Michael Christie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Christie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Christie more than expected).

Fields of papers citing papers by Michael Christie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Christie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Christie. The network helps show where Michael Christie may publish in the future.

Co-authorship network of co-authors of Michael Christie

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Christie. A scholar is included among the top collaborators of Michael Christie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Christie. Michael Christie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balasubramanian, Akhila, Jodie Palmer, Michael Christie, et al.. (2025). Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial. Clinical Cancer Research. 31(22). 4644–4654.

Christie, Michael, et al.. (2025). Insights into bloodstream infections in South African paediatric burn patients: implications for antimicrobial stewardship. BMC Infectious Diseases. 25(1). 362–362.

Lee, Su Jin, et al.. (2024). Pseudoprogression following neoadjuvant chemoimmunotherapy for lung squamous cell carcinoma mimicking pulmonary metastatic disease on computed tomography: A case report and review of the literature. SHILAP Revista de lepidopterología. 19(9). 4029–4033. 1 indexed citations

Antón, A., Ryan Hutchinson, Christopher M. Hovens, et al.. (2024). An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape. PLoS ONE. 19(11). e0301943–e0301943. 3 indexed citations

Flynn, Maria, et al.. (2024). POU2F3-expressing intraepithelial small-cell carcinoma with mixed small-cell carcinoma and conventional-type urothelial carcinoma of the urinary bladder. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(5). 947–952.

Cai, Ling, Luc Girard, Owen W.J. Prall, et al.. (2023). Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical Cancer Research. 30(9). 1846–1858. 28 indexed citations

Rangamuwa, Kanishka, Michael Christie, Tracy L. Leong, et al.. (2023). P1.09-01 Anti-Cancer Immune Activation Post Bronchoscopic Thermal Ablation in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 18(11). S199–S199.

Faux, Maree C., Janet Weinstock, Alexandra L. Garnham, et al.. (2022). Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC. Cancer Research Communications. 2(2). 66–77. 7 indexed citations

Walsh, Maie, Jessica Taylor, Bryony A. Thompson, et al.. (2022). Real world outcomes and implementation pathways of exome sequencing in an adult genetic department. Genetics in Medicine. 24(7). 1536–1544. 4 indexed citations

10.

Lasocki, Arian, Michael E. Buckland, Katharine J. Drummond, et al.. (2022). Conventional MRI features can predict the molecular subtype of adult grade 2–3 intracranial diffuse gliomas. Neuroradiology. 64(12). 2295–2305. 18 indexed citations

11.

Rangamuwa, Kanishka, Clare E. Weeden, Marie-Liesse Asselin-Labat, et al.. (2021). Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. Translational Lung Cancer Research. 10(6). 2842–2857. 56 indexed citations

12.

Rangamuwa, Kanishka, Tracy L. Leong, Steven Bozinovski, et al.. (2021). Increase in tumour PD-L1 expression in non-small cell lung cancer following bronchoscopic thermal vapour ablation. Translational Lung Cancer Research. 10(6). 2858–2864. 13 indexed citations

13.

Christie, Michael, et al.. (2020). Solitary subependymal giant cell astrocytoma: Case report and review of the literature. Journal of Clinical Neuroscience. 82(Pt A). 26–28. 8 indexed citations

14.

Lee, Belinda, Ryan Hutchinson, Hui‐Li Wong, et al.. (2017). Emerging biomarkers for immunomodulatory cancer treatment of upper gastrointestinal, pancreatic and hepatic cancers. Seminars in Cancer Biology. 52(Pt 2). 241–252. 12 indexed citations

15.

Tie, Jeanne, Isaac Kinde, Yuxuan Wang, et al.. (2014). Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).. Journal of Clinical Oncology. 32(15_suppl). 11015–11015. 15 indexed citations

16.

Hunter, Sally M., Kylie L. Gorringe, Michael Christie, et al.. (2012). Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations. Clinical Cancer Research. 18(19). 5267–5277. 52 indexed citations

17.

Ryland, Georgina L., Sally M. Hunter, Maria Doyle, et al.. (2012). RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. The Journal of Pathology. 229(3). 469–476. 88 indexed citations

18.

Jorissen, Robert N., Peter Gibbs, Michael Christie, et al.. (2009). Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clinical Cancer Research. 15(24). 7642–7651. 343 indexed citations

19.

Christie, Michael, et al.. (2007). Effect of Sampling Strategies on Prediction Uncertainty Estimation. Proceedings of SPE Reservoir Simulation Symposium. 16 indexed citations

20.

Christie, Michael & Martin K. Oehler. (2006). Molecular pathology of epithelial ovarian cancer. The Journal of the British Menopause Society. 12(2). 57–63. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact